The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells. 1982

T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand

Intracellular deoxynucleoside triphosphate pools of normal bone marrow, thymocytes and cells from patients with ALL and AML were measured after 2 h incubation with deoxycoformycin (dCF) 10(-5) M and deoxyadenosine (AdR) 10(-4) M in vitro and after another 30 min incubation in the absence of dCF and AdR ('chase' experiment). Incubation with dCF and AdR resulted in a significant rise of dATP concentrations in all groups (the highest rises occurring in the leukaemic groups particularly in AML and Thy-ALL). The concentrations of the other three deoxyribonucleoside triphosphates fell in all groups. The dATP level fell during the 'chase' period but in Thy-ALL and thymocytes this fall was insignificant and slower than in the other groups. This suggests that not only intracellular build-up of dATP but also the capacity of the cell to degrade dATP is important for in vivo cytotoxicity of dCF treatment. These results help to explain the differences in response to dCF of the different leukaemias.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D003070 Coformycin A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.
D003838 Deoxyadenine Nucleotides Adenine nucleotides which contain deoxyribose as the sugar moiety. Deoxyadenosine Phosphates,Nucleotides, Deoxyadenine,Phosphates, Deoxyadenosine
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D003854 Deoxyribonucleotides A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group. Deoxyribonucleotide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
October 1982, Blood,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
February 1988, Human immunology,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
July 1979, Journal of immunology (Baltimore, Md. : 1950),
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
December 1985, The Tohoku journal of experimental medicine,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
October 2000, Journal of cellular biochemistry,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
June 1990, Journal of cellular biochemistry,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
August 1978, Cancer research,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
February 1984, Cancer research,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
April 1982, Biochemical pharmacology,
T Sylwestrowicz, and A Piga, and P Murphy, and K Ganeshaguru, and N H Russell, and H G Prentice, and A V Hoffbrand
May 1988, The Journal of biological chemistry,
Copied contents to your clipboard!